Cargando…
Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer
BACKGROUND: Immune checkpoint inhibitors (ICIs) have altered the clinical management of non-small cell lung cancer (NSCLC). However, the low response rate, severe immune-related adverse events (irAEs), and hyperprogressive disease following ICIs monotherapy require attention. Combination therapy may...
Autores principales: | Yu, Dingyi, Yang, Penghui, Lu, Xiaoyan, Huang, Shaoze, Liu, Li, Fan, Xiaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332015/ https://www.ncbi.nlm.nih.gov/pubmed/37430270 http://dx.doi.org/10.1186/s12964-023-01184-3 |
Ejemplares similares
-
Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice
por: Zhang, Shiyu, et al.
Publicado: (2022) -
An Overview of Systematic Reviews of Shenmai Injection for Healthcare
por: Lu, Ling-yan, et al.
Publicado: (2014) -
Quality monitoring of Shenmai injection by HPLC pharmacodynamic fingerprinting
por: Yang, Geng, et al.
Publicado: (2023) -
Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis
por: Zhang, Chi, et al.
Publicado: (2023) -
Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction
por: Zheng, Zhaohai, et al.
Publicado: (2022)